Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 3,471 | 3,338 | 1,819 | 2,300 | 2,091 |
| Operating Income | -3,471 | -3,338 | -1,819 | -2,300 | -2,091 |
| Other Income | 1 | 3 | 8 | 23 | 32 |
| Pre-tax Income | -3,469 | -3,336 | -1,811 | -2,277 | -2,059 |
| Net Income Continuous | -3,469 | -3,336 | -1,811 | -2,277 | -2,059 |
| Net Income | $-3,469 | $-3,336 | $-1,811 | $-2,277 | $-2,059 |
| EPS Basic Total Ops | -156.25 | -150.00 | -100.00 | -137.50 | -100.00 |
| EPS Basic Continuous Ops | -157.68 | -152.78 | -100.24 | -135.56 | -106.74 |
| EPS Diluted Total Ops | -156.25 | -150.00 | -100.00 | -137.50 | -100.00 |
| EPS Diluted Continuous Ops | -157.68 | -152.78 | -100.24 | -135.56 | -106.74 |
| EBITDA(a) | $-3,471 | $-3,338 | $-1,819 | $-2,300 | $-2,091 |